Asia Pacific FISH Imaging Systems Market was worth USD 131.7 million in 2018 and estimated to be growing at a CAGR of 10.2%, to reach USD 214.6 million by 2023. FISH imaging system is a type of molecular cytogenetic technique which utilizes fluorescent probes.
Probes are generally derived from the fragments of DNA that were isolated, purified and amplified for use in Human Genome Project. There are a lot of imaging techniques like Single molecule RNA, Fiber, and Flow MA. FISH is mostly used in clinical studies as well as to compare the genomes of two biological species. FISH is also used in microbial ecology sector to identify microorganisms.
Factors accountable for the growth of market are increasing prevalence of cancer and other chronic diseases, growing expenditure on healthcare and increasing financial support for Research and Development in the field of genomics and increasing awareness regarding the advantages of FISH Imaging Systems. But, factors like expensive prices and lengthy processing techniques are hindering the advancement of market.
The Asia Pacific market for FISH Imaging Systems is segmented based on Product, Application and End Users. Based on Products it is divided into Microscopes, Instruments, Automated Cell Analyzers and Services. Based on Application it is divided into Cancer Diagnosis, Genetic Disease Diagnosis and Others. Based on End Users it is divided into Diagnostic Laboratories, Research and Academic Institutes and Others. Based on geographical analysis, the market is divided into regions of China, India, Japan, South Korea and Australia. China holds the major share in the market due to presence of market leaders as well as the presence of a stellar healthcare system. India is the fastest growing region due to increasing disposable income, growing awareness and increasing adoption rate. Based on End Users, Diagnostic Laboratories hold the major share in the market due to their easy accessibility and increasing necessity.
Some of the key players dominating this market include BIOVIEW, West Medica Produktions- und Handels- GmbH, PerkinELmer, Inc., Leica Biosystems Nussloch GmbH, Bio Rad Laboratories, Inc., BioTek Instruments, Inc., GE Healthcare, Thermo Fisher Scientific, Inc., TissueGnostics GmbH, Applied Spectral Imaging.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Instruments
5.1.3 Microscopes
5.1.4 Automated Cell Analyzers
5.1.5 Consumables
5.1.6 Software
5.1.7 Others
5.1.8 Y-o-Y Growth Analysis, By Product
5.1.9 Market Attractiveness Analysis, By Product
5.1.10 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Cancer Diagnosis
5.2.2.1 Lung Cancer
5.2.2.2 Breast Cancer
5.2.2.3 Others
5.2.3 Genetic Disease Diagnosis
5.2.4 Others
5.2.5 Y-o-Y Growth Analysis, By Application
5.2.6 Market Attractiveness Analysis, By Application
5.2.7 Market Share Analysis, By Application
5.3 End User
5.3.1 Introduction
5.3.2 Diagnostic Labs
5.3.3 Academic and Research Institutes
5.3.4 Others
5.3.5 Y-o-Y Growth Analysis, By End User
5.3.6 Market Attractiveness Analysis, By End User
5.3.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.1.5.4 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 BIOVIEW
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 West Medica Produktions- und Handels- GmbH
8.3 PerkinELmer, Inc
8.4 Leica Biosystems Nussloch GmbH
8.5 Bio Rad Laboratories, Inc.
8.6 BioTek Instruments, Inc.
8.7 GE Healthcare
8.8 Thermo Fisher Scientific, Inc.
8.9 TissueGnostics GmbH
8.10 Applied Spectral Imaging
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
